Keywords: لیکسسناتید; Type 2 diabetes mellitus; GLP-1 agonist; Lixisenatide
مقالات ISI لیکسسناتید (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Keywords: لیکسسناتید; albiglutide; dulaglutide; exenatide; GLP-1 receptor agonists; liraglutide; lixisenatide;
Keywords: لیکسسناتید; Flexibility; Glycaemic control; Lixisenatide; Type 2 diabetes mellitus; Self-monitored plasma glucose;
Keywords: لیکسسناتید; Exenatide; Exenatide once-weekly; GLP-1 receptor agonists; Liraglutide; Lixisenatide; Type 2 diabetes
Keywords: لیکسسناتید; Cognitive function; Glucagon-like peptide-1 (GLP-1); Hippocampus; Lixisenatide;
Keywords: لیکسسناتید; Glucagon-like peptide-1 receptor agonist; Lixisenatide; Gastric emptying; Postprandial blood glucose; Type 2 diabetes;
Lixisenatide ameliorates cerebral ischemia-reperfusion injury via GLP-1 receptor dependent/independent pathways
Keywords: لیکسسناتید; Stroke; Cerebral ischemia/reperfusion; GLP-1; Lixisenatide; Exendin(9â39);
Lixisenatida en pacientes con diabetes tipo 2 y obesidad: más allá del control glucémico
Keywords: لیکسسناتید; Diabetes tipo 2; Obesidad; Análogos de GLP-1; Lixisenatida; Control metabólico; Type 2 diabetes; Obesity; GLP-1; Lixisenatide; Metabolic control;
Lixisenatide attenuates the detrimental effects of amyloid β protein on spatial working memory and hippocampal neurons in rats
Keywords: لیکسسناتید; Lixisenatide; Amyloid β protein; Working memory; Cell viability; Akt-MEK1/2 signal pathway; Intracellular calcium concentration;
Long-term Cost-effectiveness of Two GLP-1 Receptor Agonists for the Treatment of Type 2 Diabetes Mellitus in the Italian Setting: Liraglutide Versus Lixisenatide
Keywords: لیکسسناتید; cost; cost-effectiveness; diabetes mellitus; Italy; liraglutide; lixisenatide;
GLP-1 RAs as compared to prandial insulin after failure of basal insulin in type 2 diabetes: lessons from the 4B and Get-Goal DUO 2 trials
Keywords: لیکسسناتید; GLP-1 receptor agonists; exenatide; lixisenatide; basal insulin
Pleiotropic effects of insulin and GLP-1 receptor agonists: Potential benefits of the association
Keywords: لیکسسناتید; Exenatide; Liraglutide; Lixisenatide; NASH; Cardiovascular; Heart; Liver
Once-daily prandial lixisenatide versus once-daily rapid-acting insulin in patients with type 2 diabetes mellitus insufficiently controlled with basal insulin: analysis of data from five randomized, controlled trials
Keywords: لیکسسناتید; Lixisenatide; Basal insulin; Basal + RAI; GLP-1 receptor agonist;
Effects of the GLP-1 receptor agonist lixisenatide on postprandial glucose and gastric emptying - preclinical evidenceâ
Keywords: لیکسسناتید; Lixisenatide; GLP-1 receptor agonists; Gastric emptying; Postprandial glucose; Type 2 diabetes mellitus;
Beneficial effects of once-daily lixisenatide on overall and postprandial glycemic levels without significant excess of hypoglycemia in Type 2 diabetes inadequately controlled on a sulfonylurea with or without metformin (GetGoal-S)
Keywords: لیکسسناتید; GLP-1 receptor agonists; Lixisenatide; Sulfonylurea; Type 2 diabetes;
Lixisenatide plus basal insulin in patients with type 2 diabetes mellitus: a meta-analysis
Keywords: لیکسسناتید; Lixisenatide; Combination; Basal insulin; Prandial; Meta-analysis;
Review ArticleThe incretin hormones glucagonlike peptide 1 and glucose-dependent insulinotropic polypeptide are neuroprotective in mouse models of Alzheimer's disease
Keywords: لیکسسناتید; Alzheimer's disease; Parkinson's disease; Growth factors; GLP-1; Liraglutide; Lixisenatide;
Lixisenatide rescues spatial memory and synaptic plasticity from amyloid β protein-induced impairments in rats
Keywords: لیکسسناتید; AD; Alzheimer's disease; Aβ; amyloid β; ANOVA; analysis of variance; BBB; blood-brain barrier; DPPIV; DPPIV dipeptidyl peptidase IV; fEPSPs; Field excitatory postsynaptic potentials; GLP-1; glucagon-like peptide-1; GLP-1R; GLP-1 receptor; GSK3β; gl
GLP-1 for type 2 diabetes
Keywords: لیکسسناتید; GLP-1; DPP-4 inhibition; Type 2 diabetes; Exenatide; Liraglutide; Albiglutide; Taspoglutide; Lixisenatide; Sitagliptin; Vildagliptin; Saxagliptin; Alogliptin; Linagliptin
Pharmacological profile of lixisenatide: A new GLP-1 receptor agonist for the treatment of type 2 diabetes
Keywords: لیکسسناتید; Type 2 diabetes mellitus; Glucagon-like peptide-1 (GLP-1) receptor agonist; Lixisenatide; Preclinical; Pharmacology